Galecto Publishes Results Showing Safety and Efficacy of the GB0139 Inhaled Galectin-3 Inhibitor in Hospitalized COVID-19 Patients on Standard of Care
Results Support Favorable Safety and Tolerability Profile and Target Engagement of GB0139 and Potential for…